1 Intended use in clinical setting, route of administration, dosage form, delivery systems;
2 Dosage strength(s);
3 Container closure system
4 Therapeutic moiety release or delivery and attributes affecting pharmacokinetic characteristics
5 Drug product quality criteria appropriate for the intended marketed product.
1 CONTROL OF INPUT MATERIAL ATTRIBUTES based on an understanding of their impact on processability or product quality;
2 Product specification(s);
3 Controls for unit operations that have an impact on downstream processing or product quality
4 In-process or real-time release testing in lieu of end-product testing
5 A monitoring program for verifying multivariate prediction models.